Adult Asthma - Clinical Study [US,CA] (Email,Social,Banner,Native,Push,SEO,Search,Brand Bidding) - CPL | oDigger
Join the Community
Top Networks
Top Categories
    Top Searches

      Adult Asthma - Clinical Study [US,CA] (Email,Social,Banner,Native,Push,SEO,Search,Brand Bidding) - CPL

      Promote this offer through the SmartAdv Affiliate Network

      Offer Details:


      Offer Name:

      Adult Asthma - Clinical Study [US,CA] (Email,Social,Banner,Native,Push,SEO,Search,Brand Bidding) - CPL

      Preview:

      Preview Landing Page

      Categories:

      Health

      Network:

      SmartAdv

      Status:

      Active

      Last Updated:

      May 19, 2024

      Date Added:

      May 19, 2024

      Payouts:

      $25.00 / cpa

      Countries:

      		 US / CA
      Join SmartAdv

      Affiliate Offer Description:

      You must be a member of SmartAdv to promote this offer. Click Here to join their network.
      Conversion Point: Valid Form Fill Ages: 18+ Gender: Any Compensation: Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated for time and travel. GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Qualifications: - Doctor must have already diagnosed you with asthma for at least one year - Must currently use a daily inhaler that contains a corticosteroid? Examples include: Flovent HFA, Pulmicort, Qvar, Advair, Breo, Dulera, Azmacort. Rescue inhalers such as albuterol should not be counted. - In the past year, must have had an asthma exacerbation (a worsening of symptoms) that required: Treatment with systemic (oral, IV, injectable) corticosteroids for at least 3 days or Led to an emergency room/urgent care visit or hospitalization - Cannot also be diagnosed with the following: Cystic fibrosis, Pulmonary fibrosis, Chronic obstructive pulmonary disease (COPD), Emphysema - Cannot currently smoke Study Description: The purpose of this clinical study is to test if the use of an approved asthma medication, dupilumab, can preserve long term lung function in people with moderate to severe asthma. If you are eligible, you will be asked to attend a screening visit to determine if you can enroll in the study. If enrolled, you will receive either dupilumab or placebo to be given as an injection once every 2 weeks for 3 years. You will have a 2:1 chance of being assigned dupilumab versus the placebo. The study medication will be given alongside current standard of care asthma therapy. Your total participation will last approximately 3 years and 4 months and you will be asked to attend 15 doctor’s visits. During these visits, you will complete various diagnostic and laboratory tests. The doctor’s office conducting the study will be able to provide you with more information about the study requirements. Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated for time and travel.
      SmartAdv

      About: SmartAdv

      SmartAdv prides itself on service and support as our state of the art infrastructure operates 24/7/365 and our account managers are at your beck and c ... Read More

      SmartAdv prides itself on service and support as our state of the art infrastructure operates 24/7/365 and our account managers are at your beck and call to provide concierge service to all of our customers. Get incredible offers to monetize websites and campaigns, in addition to generating high click-through and sales ratios, not to mention excellent payouts and terms.

      Build traffic in popular verticals and increase your profitability. We work with you to setup and maintain your solutions so you can focus on your business and increase your profits, without wasting time on technology.

      Join the industry's premier network and come grow with us!
      Read Less

      Similar offers

      var AdButler = AdButler || {}; AdButler.ads = AdButler.ads || []; var abkw = window.abkw || ''; var plc378612 = window.plc378612 || 0; var plc378614 = window.plc378614 || 0; var plc378613 = window.plc378613 || 0; var plc389895 = window.plc389895 || 0; var plc389896 = window.plc389896 || 0; var plc389897 = window.plc389897 || 0; var plc389898 = window.plc389898 || 0; var plc389899 = window.plc389899 || 0; var plc389900 = window.plc389900 || 0; var plc378615 = window.plc378615 || 0; var plc378616 = window.plc378616 || 0; var plc378623 = window.plc378623 || 0; var masterObject = { topAd: { id: 378612, counter: plc378612 }, homepageAd2: { id: 378614, counter: plc378614 }, sidebarTopAd: { id: 378613, counter: plc378613 }, sidebarAd1: { id: 389895, counter: plc389895 }, sidebarAd2: { id: 389896, counter: plc389896 }, sidebarAd3: { id: 389897, counter: plc389897 }, sidebarAd4: { id: 389898, counter: plc389898 }, sidebarAd5: { id: 389899, counter: plc389899 }, sidebarAd6: { id: 389900, counter: plc389900 }, sidebarBottomAd: { id: 378615, counter: plc378615 }, bottomAd: { id: 378616, counter: plc378616 }, offerTopAd: { id: 378623, disabled: false, counter: plc378623 } }; Object.keys(masterObject).forEach(function(key) { var entry = masterObject[key]; var element = document.getElementById(key); if (element && !entry.disabled) { document.getElementById(key).innerHTML = `
      `; AdButler.ads.push({ handler: function(opt) { AdButler.register( 161318, entry.id, [728,90], 'placement_' + entry.id + '_' + opt.place, opt ) }, opt: { place: entry.counter++, keywords: abkw, domain: 'servedbyadbutler.com', click: 'CLICK_MACRO_PLACEHOLDER' } }); } });